• Mon news: Autolus enters CAR-T race with FDA approval. FDA clears clinical hold on Novavax. AbbVie schizophrenia trial failure. Cigna not pursuing Humana. GSK leaving BIO. See more on our front page

Nabbing late-stage drug, PTC acquires gene therapy startup Agilis for $200M in cash/stock

Quote
cafead

cafead

Administrator
Staff member
  • cafead   Jul 19, 2018 at 11:42: PM
via After its bumpy road with a thrice-failed Duchenne drug, the team at PTC Therapeutics has been busy putting new irons in its fire. In its latest effort, the New Jersey company announced Thursday that it’s acquiring a gene therapy startup with a few promising drugs in its pipeline.

article source
 




Top Bottom
Back
Quote